Hôpital Maisonneuve-Rosemont is a hospital in Montreal, Quebec, Canada, located in the boroughs of Rosemont–La Petite-Patrie and Mercier-Hochelaga-Maisonneuve. It serves the eastern part of the city and offers 800 beds. It employs 5,000 people and 3,000 students annually.

There are 800 beds in Hopital Maisonneuve- Rosemont; Rheumatology.

During the past decade, Hopital Maisonneuve- Rosemont; Rheumatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Maisonneuve- Rosemont; Rheumatology" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Maisonneuve- Rosemont; Rheumatology" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Hopital Maisonneuve- Rosemont; Rheumatology" in a lesser frequency.

Most popular intervention types in "Hopital Maisonneuve- Rosemont; Rheumatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Leflunomide" (1 trials), "Ocrelizumab" (1 trials), "Placebo" (1 trials) and "Placebo to methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Maisonneuve- Rosemont; Rheumatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Maisonneuve- Rosemont; Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Maisonneuve- Rosemont; Rheumatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Maisonneuve- Rosemont; Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".